KATHERINE VAN HANDEL: Open Payments
NPI 1174218226 · NEENAH, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,029 in 56 payments from 13 companies in 2025. Trend: 2023 $1,411 · 2024 $1,390 · 2025 $2,029
Food & beverage: $1,930Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $465 |
| Madrigal Pharmaceuticals | 11 | $457 |
| ABBVIE INC. | 20 | $450 |
| Gilead Sciences, Inc. | 4 | $237 |
| Regeneron Healthcare Solutions, Inc. | 4 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Elucent Medical | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, Epclusa, Livdelzi, SKYRIZI, ENTYVIO.
Industry payments across WI — which companies pay providers there.
